[HTML][HTML] SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods

BA Oliveira, LC Oliveira, EC Sabino… - Revista do Instituto de …, 2020 - SciELO Brasil
ABSTRACT Coronavirus disease 2019 (COVID-19) is an infectious disease initially reported
in China and currently worldwide dispersed caused by a new coronavirus (SARS-CoV-2 or …

Review of current advances in serologic testing for COVID-19

AP Espejo, Y Akgun, AF Al Mana… - American journal of …, 2020 - academic.oup.com
Objectives To examine and summarize the current literature on serologic methods for the
detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

L Grzelak, S Temmam, C Planchais… - Science translational …, 2020 - science.org
It is of paramount importance to evaluate the prevalence of both asymptomatic and
symptomatic cases of SARS-CoV-2 infection and their differing antibody response profiles …

Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals

F Gong, Y Dai, T Zheng, L Cheng… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Marked progress is achieved in understanding the physiopathology of
coronavirus disease 2019 (COVID-19), which caused a global pandemic. However, the …

Cluster of COVID-19 in northern France: a retrospective closed cohort study

A Fontanet, L Tondeur, Y Madec, R Grant, C Besombes… - MedRxiv, 2020 - medrxiv.org
Summary Background The Oise department in France has been heavily affected by COVID-
19 in early 2020. Methods Between 30 March and 4 April 2020, we conducted a …

Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients

Y Li, D Lai, H Zhang, H Jiang, X Tian, M Ma… - Cellular & molecular …, 2020 - nature.com
COVID-19 is caused by SARS-CoV-2. 1, 2 By July 25, 2020, globally, 15,672,841 diagnosed
cases and 638,352 deaths were reported (https://coronavirus. jhu. edu/map. html). 3 High …

[PDF][PDF] “Immunity passports” in the context of COVID-19: scientific brief, 24 April 2020

World Health Organization - 2020 - apps.who.int
WHO has published guidance on adjusting public health and social measures for the next
phase of the COVID-19 response. 1 Some governments have suggested that the detection …

SARS-CoV-2-specific ELISA development

V Roy, S Fischinger, C Atyeo, M Slein, C Loos… - Journal of …, 2020 - Elsevier
Critical to managing the spread of COVID-19 is the ability to diagnose infection and define
the acquired immune response across the population. While genomic tests for the novel …

The immunodominant and neutralization linear epitopes for SARS-CoV-2

S Lu, X Xie, L Zhao, B Wang, J Zhu, T Yang, G Yang… - Cell reports, 2021 - cell.com
Although vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are under development, the antigen epitopes on the virus and their immunogenicity are …

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma

L Farrera-Soler, JP Daguer, S Barluenga, O Vadas… - PloS one, 2020 - journals.plos.org
A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a
current pandemic (COVID-19) with devastating consequences in public health and …